With this extension, IXCHIQ®, the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU).

Chemical producers in the U.S. are adopting GenAI and other new technologies to improve efficiency, innovation and sustainability, according to a new research report published today by Information ...

Alcatel is planning to restart mobile phone sales in India – or, more accurately perhaps, French technology brand Alcatel, ...